Pro-cognitive drug trial failures in schizophrenia: the need for cognitive screening?
Webinars Back to resource centre 11 January 2023 Pro-cognitive drug trial failures in schizophrenia: the need for cognitive screening? Despite a wealth of research, pharmaceutical companies have thus far been unsuccessful in their attempts to address cognitive impairment in schizophrenia. This begs the question: are these compounds truly ineffective or has trial methodology itself been a limiting factor in successfully
Pro-cognitive drug trial failures in schizophrenia: the need for cognitive screening? Read More »
